Genelux Non Currrent Assets Other from 2010 to 2025
| GNLX Stock | 3.08 0.05 1.65% |
Non Currrent Assets Other | First Reported 2010-12-31 | Previous Quarter 105.8 K | Current Value 100.5 K | Quarterly Volatility 393.9 K |
Check Genelux Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genelux Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 883.5 K, Interest Expense of 4.8 M or Other Operating Expenses of 16.8 M, as well as many indicators such as Price To Sales Ratio of 9.7 K, Dividend Yield of 0.0 or PTB Ratio of 2.97. Genelux financial statements analysis is a perfect complement when working with Genelux Common Valuation or Volatility modules.
Genelux | Non Currrent Assets Other |
Latest Genelux Common's Non Currrent Assets Other Growth Pattern
Below is the plot of the Non Currrent Assets Other of Genelux Common over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Genelux Common's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genelux Common's overall financial position and show how it may be relating to other accounts over time.
| Non Currrent Assets Other | 10 Years Trend |
|
Non Currrent Assets Other |
| Timeline |
Genelux Non Currrent Assets Other Regression Statistics
| Arithmetic Mean | 183,144 | |
| Geometric Mean | 101,572 | |
| Coefficient Of Variation | 215.09 | |
| Mean Deviation | 184,607 | |
| Median | 80,000 | |
| Standard Deviation | 393,917 | |
| Sample Variance | 155.2B | |
| Range | 1.6M | |
| R-Value | 0.27 | |
| Mean Square Error | 154.3B | |
| R-Squared | 0.07 | |
| Significance | 0.32 | |
| Slope | 22,175 | |
| Total Sum of Squares | 2.3T |
Genelux Non Currrent Assets Other History
About Genelux Common Financial Statements
Genelux Common investors use historical fundamental indicators, such as Genelux Common's Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genelux Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Currrent Assets Other | 105.8 K | 100.5 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Genelux Stock Analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.